The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

China's pharmaceutical industry surges on ageing demand and global expansion, with revenue forecast to top US$2.1 trillion by ...

Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.